1.1 Death or dependence at end of follow‐up |
7 |
42034 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
0.95 [0.91, 0.99] |
1.1.1 Aspirin versus control |
5 |
41604 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
0.95 [0.91, 0.99] |
1.1.2 PF‐03049423 versus control |
1 |
133 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
1.15 [0.58, 2.28] |
1.1.3 Clopidogrel loading dose versus control |
1 |
297 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
0.80 [0.45, 1.42] |
1.2 Deaths from any cause during treatment period |
8 |
41483 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
0.92 [0.85, 1.00] |
1.2.1 Aspirin versus control |
4 |
41291 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
0.92 [0.85, 1.00] |
1.2.2 Aspirin plus dipyridamole versus control |
1 |
80 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
1.47 [0.43, 4.99] |
1.2.3 Ticlopidine versus control |
3 |
112 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
0.12 [0.01, 1.20] |
1.3 Deaths from any cause during follow‐up |
10 |
41929 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
0.93 [0.87, 0.98] |
1.3.1 Aspirin versus control |
5 |
41604 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
0.92 [0.87, 0.98] |
1.3.2 Aspirin plus dipyridamole versus control |
1 |
80 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
1.47 [0.43, 4.99] |
1.3.3 Ticlopidine versus control |
3 |
112 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
0.12 [0.02, 0.88] |
1.3.4 PF‐03049423 versus control |
1 |
133 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
1.91 [0.74, 4.93] |
1.4 Deep venous thrombosis during treatment period |
2 |
133 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
0.78 [0.36, 1.67] |
1.4.1 Aspirin plus dipyridamole versus control |
1 |
80 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
0.35 [0.13, 0.95] |
1.4.2 Ticlopidine versus control |
1 |
53 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
2.37 [0.72, 7.73] |
1.5 Pulmonary embolism during treatment period |
7 |
41042 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
0.71 [0.53, 0.96] |
1.5.1 Aspirin versus control |
3 |
40850 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
0.71 [0.53, 0.97] |
1.5.2 Aspirin plus dipyridamole versus control |
1 |
80 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
7.39 [0.15, 372.38] |
1.5.3 Ticlopidine versus control |
3 |
112 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
0.13 [0.01, 2.06] |
1.6 Recurrent ischaemic/unknown stroke during treatment period |
9 |
41652 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
0.79 [0.70, 0.88] |
1.6.1 Aspirin versus control |
4 |
41163 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
0.78 [0.69, 0.88] |
1.6.2 Aspirin plus dipyridamole versus control |
1 |
80 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
Not estimable |
1.6.3 Ticlopidine versus control |
3 |
112 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
Not estimable |
1.6.4 Clopidogrel loading dose versus control |
1 |
297 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
1.10 [0.59, 2.06] |
1.7 Symptomatic intracranial haemorrhage during treatment period |
9 |
41652 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
1.18 [0.97, 1.44] |
1.7.1 Aspirin versus control |
4 |
41163 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
1.17 [0.96, 1.43] |
1.7.2 Aspirin plus dipyridamole versus control |
1 |
80 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
1.00 [0.14, 7.38] |
1.7.3 Ticlopidine versus control |
3 |
112 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
2.70 [0.36, 20.26] |
1.7.4 Clopidogrel loading dose versus control |
1 |
297 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
0.99 [0.14, 7.12] |
1.8 Recurrent stroke/intracranial haemorrhage during treatment period |
7 |
41042 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
0.88 [0.79, 0.97] |
1.8.1 Aspirin versus control |
3 |
40850 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
0.87 [0.79, 0.97] |
1.8.2 Aspirin plus dipyridamole versus control |
1 |
80 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
1.00 [0.14, 7.38] |
1.8.3 Ticlopidine versus control |
3 |
112 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
2.70 [0.36, 20.26] |
1.9 Major extracranial haemorrhage during treatment period |
7 |
41042 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
1.69 [1.35, 2.11] |
1.9.1 Aspirin versus control |
3 |
40850 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
1.69 [1.35, 2.11] |
1.9.2 Aspirin plus dipyridamole versus control |
1 |
80 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
Not estimable |
1.9.3 Ticlopidine versus control |
3 |
112 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
Not estimable |
1.10 Complete recovery from stroke (post hoc) |
2 |
40541 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
1.06 [1.01, 1.11] |
1.10.1 Aspirin versus control |
2 |
40541 |
Peto Odds Ratio (Peto, Fixed, 95% CI) |
1.06 [1.01, 1.11] |